MedPath

Evaluation of novel coronavirus pneumonia patients (COVID-19) treated with Chinese Medicine

Not Applicable
Recruiting
Conditions
novel coronavirus pneumonia
Registration Number
ITMCTR2200005898
Lead Sponsor
The First Affiliated Hospital of Henan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Novel coronavirus pneumonia patients were diagnosed.
2. Over 18 years old;
3. Voluntarily accept treatment and sign informed consent.

Exclusion Criteria

1. Patients who have not been treated with TCM syndrome differentiation or whose syndrome differentiation treatment is less than 3 days;
2. Dementia, various mental diseases and other patients with dementia who are unable to communicate.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
transformation severe classification rate;Nucleic acid negative conversion rate;Nucleic acid negative time;
Secondary Outcome Measures
NameTimeMethod
Other;Disease outcome;CRP;routine blood test;Biochemical examination;D-dimer;Clinical symptom score;Safety index;Immunological examination;Heat retreat time;PCT;Chest imaging changes;
© Copyright 2025. All Rights Reserved by MedPath